How do you improve compliance?

Pediatrics

Volumn 115, Issue 6, 2005, Pages

  Winnick, Sheldon ^a,b   Lucas, David O ^c   Hartman, Adam L ^d,e   Toll, David ^a  

^a University of California ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Lucas Science   (United States)

^d Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adherence; Compliance; Cost; Dose; Duration; Education; Medication; Palatability; Physician patient; Practice; Prescription

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; HEALTH CARE; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT FAILURE; COMMUNICATION DISORDER; DRUG THERAPY; FAMILY SIZE; HUMAN RELATION; INFORMATION PROCESSING; PATIENT; PEDIATRICS; QUESTIONNAIRE; REVIEW; STATISTICS; TREATMENT REFUSAL;

COMMUNICATION BARRIERS; DATA COLLECTION; DRUG THERAPY; FAMILY CHARACTERISTICS; HUMANS; PATIENT COMPLIANCE; PATIENT DROPOUTS; PEDIATRICS; PHYSICIAN-PATIENT RELATIONS; PROFESSIONAL-FAMILY RELATIONS; QUESTIONNAIRES; TREATMENT REFUSAL;

EID: 26844504701     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1133     Document Type: Article

References (82)

1. Matsui DM. Drug compliance in pediatrics. Pediatr Clin North Am. 1997;44:1-14
2. Noncompliance With Medications: An Economic Tragedy With Important Implications for Health Care Reform. Baltimore, MD: Task Force for Compliance; 1994
3. Jones JG. Compliance with pediatric therapy. Clin Pediatr (Phila). 1983;22:262-265
4. Elliott V, Morgan S, Day S, Mollerup LS, Wang W. Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23:112-116
5. Newell SA, Bowman JA, Cockburn JD. A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease. Prev Med. 1999;29:535-548
6. Ellis S, Shumaker S, Sieber W, Rand C. Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Control Clin Trials. 2000;21(suppl):218S-225S
7. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443-455
8. Cramer JA. Relationship between medication compliance and medical outcomes. Am J Health Syst Pharm. 1995;52(suppl 3):S27-S29
9. Spath P. Continuity of care means better instruction on meds. Hosp Peer Rev. 2000;25:53-55
10. Thompson SM, Dahlquist LM, Koenning GM, Bartholomew LK. Brief report: adherence-facilitating behaviors of a multidisciplinary pediatric rheumatology staff. J Pediatr Psychol. 1995;20:291-297
11. Davis MC, Tucker CM, Fennell RS. Family behavior, adaptation, and treatment adherence of pediatric nephrology patients. Pediatr Nephrol. 1996;10:160-166
12. Bell F. Post-renal transplant compliance. J Child Health Care. 2000;4:5-9
13. Meyers KE, Thomson PD, Weiland H. Noncompliance in children and adolescents after renal transplantation. Transplantation. 1996;62:186-189
14. Sanz EJ. Concordance and children's use of medicines. BMJ. 2003;327:858-860
15. Liptak GS. Enhancing patient compliance in pediatrics. Pediatr Rev. 1996;17:128-134
16. Bernstein GA, Anderson LK, Hektner JM, Realmuto GM. Imipramine compliance in adolescents. J Am Acad Child Adolesc Psychiatry. 2000;39:284-291
17. Fadiman A. The Spirit Catches You and You Fall Down: A Hmong Child, Her American Doctors, and the Collision of Two Cultures. New York, NY: Farrar Straus & Giroux; 1998
18. Galanti G. Caring for Patients From Different Cultures: Case Studies From American Hospitals. Philadelphia, PA: University of Pennsylvania Press; 1997
19. Bartlett SJ, Lukk P, Butz A, Lampros-Klein F, Rand CS. Enhancing medication adherence among inner-city children with asthma: results from pilot studies. J Asthma. 2002;39:47-54
20. Clark NM, Gong M, Schork MA, et al. Impact of education for physicians on patient outcomes. Pediatrics. 1998;101:831-836
21. Dresser GK, Bailey DG, Leake BF, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease oral availability of fexofenadine. Clin Pharmacol Ther. 2002;71:11-20
22. MASCOT Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet. 2002;360:835-841
23. Bergman AB, Werner RJ. Failure of children to receive penicillin by mouth. N Engl J Med. 1963;268:1334-1338
24. Charney E, Bynum R, Eldredge D, et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics. 1967;40:188-195
25. Schwartz RH, Wientzen RL, Pedreira F, Feroli EJ, Mella GW, Guandolo VL. Penicillin V for Group A streptococcal pharyngotonsillitis: a randomized trial of seven vs ten days' therapy. JAMA. 1981;246:1790-1795
26. Lauvau DV, Verbist L. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. J Int Med Res. 1997;25:285-295
27. Hoppe JE, Wahrenberger C. Compliance of pediatric patients with treatment involving antibiotic suspensions: a pilot study. Clin Ther. 1999;21:1193-1201
28. Hoppe JE, Blumenstock G, Grotz W, Selbmann HK. Compliance of German pediatric patients with oral antibiotic therapy: results of a nationwide survey. Pediatr Infect Dis J. 1999;18:1085-1091
29. West RJ and Lloyd JK, Leonard JV. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet. 1980;8200:873-875
30. Martinez J, Bell D, Camacho R, et al. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc. 2000;92:55-61
31. Coutts JA, Gibson NA, Payton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child. 1992;67:332-333
32. Gibson NA, Ferguson AE, Aitchison TC, Paton JY. Compliance with inhaled asthma medication in preschool children. Thorax. 1995;50:1274-1279
33. Campbell LM, Gooding TN, Aitchison WR, Smith N, Powell JA. Initial loading (400 mcg twice daily) versus static (400 mcg nocte) dose budesonide for asthma management. Int J Clin Pract. 1998;52:361-370
34. Moncica I, Oh PI, ul Qamar I, et al. A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension. Arch Dis Child. 1995;73:154-156
35. Beer S, Laver J, Benson L, et al. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets. Isr J Med Sci. 1982;18:255-258
36. Tinkelman DG, Vanderpool GE, Carroll MS, Page EG, Spangler DL. Compliance differences following administration of theophylline at six- and twelve-hour intervals. Ann Allergy. 1980;44:283-286
37. Gerber MA, Spadaccini LJ, Wright LL, Deutsch L, Kaplan EL. Twice-daily penicillin in the treatment of streptococcal pharyngitis. Am J Dis Child. 1985;139:1145-1148
38. Williams H, Jones ER, Sibert JR. Twice daily versus four times daily treatment with beclomethasone dipropionate in the control of mild childhood asthma. Thorax. 1986;41:602-605
39. Rice TD, Duggan AK, DeAngelis C. Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children. Pediatrics. 1992;89:210-214
40. Khurana CM. Issues concerning antibiotic use in child care settings. Pediatr Infect Dis J 1995;14(suppl):S34-S38
41. Dagan R, Shvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J. 1994;13:686-690
42. Gehanno P, Barry B, Bobin S, Safran C. Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children. Scand J Infect Dis. 1994;26:577-584
43. al-Shammari SA, Khoja T, al-Yamani. Compliance with short-term antibiotic therapy among patients attending primary health centres in Riyadh, Saudi Arabia. J R Soc Health. 1995;115:231-234
44. Pichichero ME, Hoeger W, Marsocci SM, Murphy AM, Francis AB, Dragalin V. Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med. 1999;153:565-570
45. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153
46. Boni S, Pontali E, De Gol P, Pedemonte P, Bassetti D. Compliance to combination antiretroviral therapy in HIV-1 infected children. Int J Antimicrob Agents. 2000;16:371-372
47. Cloyd JC, Kriel RL, Jones-Saete CM, Ong BY, Jancik JT, Remmel RP. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference. J Pediatr. 1992;120:634-638
48. Tonstad S Ose L. Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr. 1996;85:1080-1082
49. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr. 1997;130:266-273
50. Kiyingi KS, Sime L. Compliance profiles of paediatric patients in an outpatient department. P N G Med J. 1992;35:95-100
51. Babiker MA. Compliance with penicillin prophylaxis by children with impaired splenic function. Trop Geogr Med. 1986;38:119-122
52. Goode M, McMaugh A, Crisp J, Wales S, Ziegler JB. Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care. 2003;15:403-408
53. Ansah EK, Gyapong JO, Agyepong IA, Evans DB. Improving adherence to malaria treatment for children: the use of prepacked chloroquine tablets vs. chloroquine syrup. Trop Med Int Health. 2001;6:496-504
54. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus infected-children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22:56-62
55. Galant SP, van Bavel J, Finn A, et al. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol. 1999;82:273-280
56. Alessandro F, Vincenzo ZG, Marco S, Marcello G, Enrica R. Compliance with pharmacologic prophylaxis and therapy in bronchial asthma. Ann Allergy. 1994;73:135-140
57. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med. 1994;154:1349-1352
58. Edelman JM, Preston SR, Turpin JA, et al. Parent and child preference for montelukast, a leukotriene receptor antagonist, compared to inhaled cromolyn in asthmatic children ages 6 to 11 [abstract]. Eur Respir J. 1998;12(suppl 29):18s
59. Drazen JM, Israel E. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes. Am J Respir Crit Care Med. 1998;158:1697-1698
60. Maspero JF, Duenas-Meza E, Volovitz B, et al. Oral monteleukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin. 2001;17:96-104
61. Bukstein DA, Luskin AT, Bernstein A. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol. 2003;90:543-549
62. Matsui D, Barron A, Rieder MJ. Assessment of the palatability of anti-staphylococcal antibiotics in pediatric volunteers. Ann Pharmacother. 1996;30:586-588
63. Powers JL. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. Pediatr Infect Dis J. 1996;15(suppl):S30-S37
64. Powers JL, Gooch WM III, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. Pediatr Infec Dis J. 2000;19(suppl):S174- S180
65. Sjovall J, Fogh A, Huitfeldt B, Karlsson G, Nylen O. Methods for evaluating the taste of paediatric formulations in children: a comparison between the facial hedonic method and the patients' own spontaneous verbal judgement. Eur J Pediatr. 1984;141:243-247
66. Iwai N. Drug compliance of children and infants with oral antibiotics for pediatric use. Acta Paediatr Jpn. 1997;39:132-142
67. Wandstrat TL, Kaplan B. Pharmacoeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media. Pediatr Infect Dis J. 1997;16(suppl):S27-S29
68. Isenalumhe AE, Oviawe O. Polypharmacy: its cost burden and barrier to medical care in a drug-oriented health care system. Int J Health Serv. 1988;18:335-342
69. Gardner TL, Dovey SM, Tilyard MW, Gurr E. Differences between prescribed and dispensed medications. N Z Med J. 1996;109:69-72
70. Matsui D, Joubert GI, Dykxhoorn S, Rieder MJ. Compliance with prescription filling in the pediatric emergency department. Arch Pediatr Adolesc Med. 2000;154:195-198
71. Dolgin MJ, Katz ER, Doctors SR, Siegel SE. Caregivers' perceptions of medical compliance in adolescents with cancer. J Adolesc Health Care. 1986;7:22-27
72. Cromer BA, Steinberg K, Gardner L, Thornton D, Shannon B. Psychosocial determinants of compliance in adolescents with iron deficiency. Am J Dis Child. 1989;143:55-58
73. Erhardt LR. The essence of effective treatment and compliance is simplicity. Am J Hypertens. 1999;12(suppl):105S-110S
74. Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry. 2000;61(suppl 2):6-9
75. Gigliotti F, Murante BL, Weinberg GA. Short course directly observed therapy to monitor compliance with antiretroviral therapy in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2001;20:716-718
76. Watt PM, Clements B, Devadason SG, Chaney GM. Funhaler spacer: improving adherence without compromising delivery. Arch Dis Child. 2003;88:579-581
77. Williams RL, Maiman LA, Broadbent DN, et al. Educational strategies to improve compliance with an antibiotic regimen. Am J Dis Child. 1986;140:216-220
78. Pelco LE, Kissel RC, Parrish JM, Miltenberger RG. Behavioral management of oral medication administration difficulties among children: a review of literature with case illustrations. J Dev Behav Pediatr. 1987;8:90-96
79. Reimers TM, Piazza CC, Fisher WW, Parrish JM, Page TJ. Enhancing child compliance with nebulized respiratory treatment. A case study. Clin Pediatr (Phila). 1988;27:605-608
80. Ellison RS Altemeier WA. Effect of use of a measured dispensing device on oral antibiotic compliance. Clin Pediatr (Phila). 1982;21:668-671
81. Kurokawa T, Minami T, Kitamoto I, Mizuno Y, Maeda Y, Takaki S. Compliance in epileptic children in Japan. Epilepsy Res Suppl. 1988;1:147-151
82. Palanduz A, Gultekin D, Erdem E, Kayaalp N. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests. Ann Trop Paediatr. 2003;23:47-50